News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
600,056 Results
Type
Article (49402)
Company Profile (233)
Press Release (550421)
Multimedia
Podcasts (107)
Webinars (11)
Section
Business (159824)
Career Advice (3084)
Deals (29012)
Drug Delivery (107)
Drug Development (78675)
Employer Resources (178)
FDA (14498)
Job Trends (12675)
News (286990)
Policy (27787)
Tag
Academia (2504)
Academic (1)
Accelerated approval (10)
Adcomms (29)
Allergies (91)
Alliances (42922)
ALS (111)
Alzheimer's disease (1355)
Antibody-drug conjugate (ADC) (184)
Approvals (14487)
Artificial intelligence (323)
Autoimmune disease (30)
Automation (16)
Bankruptcy (255)
Best Places to Work (10372)
BIOSECURE Act (18)
Biosimilars (116)
Biotechnology (168)
Bladder cancer (100)
Brain cancer (39)
Breast cancer (390)
Cancer (3049)
Cardiovascular disease (195)
Career advice (2598)
Career pathing (33)
CAR-T (200)
CDC (26)
Cell therapy (507)
Cervical cancer (24)
Clinical research (64426)
Collaboration (1003)
Company closure (3)
Compensation (586)
Complete response letters (32)
COVID-19 (2591)
CRISPR (56)
C-suite (279)
Cystic fibrosis (109)
Data (2925)
Decentralized trials (1)
Denatured (25)
Depression (68)
Diabetes (299)
Diagnostics (5960)
Digital health (21)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (136)
Drug pricing (117)
Drug shortages (22)
Duchenne muscular dystrophy (111)
Earnings (65597)
Editorial (45)
Employer branding (25)
Employer resources (155)
Events (95132)
Executive appointments (730)
FDA (16039)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (854)
Gene editing (124)
Generative AI (27)
Gene therapy (376)
GLP-1 (786)
Government (4544)
Grass and pollen (6)
Guidances (171)
Healthcare (16906)
Huntington's disease (28)
IgA nephropathy (40)
Immunology and inflammation (152)
Immuno-oncology (8)
Indications (39)
Infectious disease (2757)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (114)
Interviews (619)
IPO (14662)
IRA (40)
Job creations (2688)
Job search strategy (2114)
Kidney cancer (14)
Labor market (48)
Layoffs (424)
Leadership (26)
Legal (5266)
Liver cancer (85)
Lung cancer (432)
Lymphoma (212)
Machine learning (11)
Management (62)
Manufacturing (346)
MASH (89)
Medical device (10367)
Medtech (10371)
Mergers & acquisitions (15053)
Metabolic disorders (815)
Multiple sclerosis (97)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (32)
Neuroscience (2024)
NextGen: Class of 2025 (5745)
Non-profit (4101)
Now hiring (43)
Obesity (413)
Opinion (262)
Ovarian cancer (103)
Pain (94)
Pancreatic cancer (125)
Parkinson's disease (176)
Partnered (20)
Patents (272)
Patient recruitment (161)
Peanut (45)
People (44135)
Pharmaceutical (60)
Pharmacy benefit managers (20)
Phase I (20409)
Phase II (28480)
Phase III (21091)
Pipeline (1592)
Policy (188)
Postmarket research (2281)
Preclinical (8781)
Press Release (52)
Prostate cancer (149)
Psychedelics (37)
Radiopharmaceuticals (271)
Rare diseases (470)
Real estate (4196)
Recruiting (73)
Regulatory (20387)
Reports (45)
Research institute (2329)
Resumes & cover letters (498)
Rett syndrome (10)
RNA editing (8)
RSV (46)
Schizophrenia (92)
Series A (149)
Series B (97)
Service/supplier (10)
Sickle cell disease (61)
Special edition (22)
Spinal muscular atrophy (146)
Sponsored (33)
Startups (3083)
State (2)
Stomach cancer (17)
Supply chain (61)
Tariffs (52)
The Weekly (80)
Vaccines (798)
Venture capital (50)
Weight loss (263)
Women's health (40)
Worklife (20)
Date
Today (43)
Last 7 days (377)
Last 30 days (1705)
Last 365 days (29407)
2025 (15749)
2024 (33237)
2023 (37849)
2022 (48387)
2021 (52204)
2020 (50069)
2019 (41752)
2018 (31647)
2017 (29667)
2016 (28361)
2015 (33079)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (819)
Alabama (59)
Alaska (6)
Arizona (137)
Arkansas (10)
Asia (40302)
Australia (6783)
California (6897)
Canada (2309)
China (677)
Colorado (289)
Connecticut (291)
Delaware (194)
Europe (82799)
Florida (1001)
Georgia (222)
Hawaii (1)
Idaho (43)
Illinois (556)
India (23)
Indiana (318)
Iowa (15)
Japan (228)
Kansas (98)
Kentucky (24)
Louisiana (13)
Maine (69)
Maryland (965)
Massachusetts (5172)
Michigan (220)
Minnesota (341)
Mississippi (2)
Missouri (85)
Montana (29)
Nebraska (18)
Nevada (67)
New Hampshire (59)
New Jersey (1980)
New Mexico (24)
New York (1976)
North Carolina (967)
North Dakota (7)
Northern California (3063)
Ohio (203)
Oklahoma (10)
Oregon (32)
Pennsylvania (1400)
Puerto Rico (13)
Rhode Island (23)
South America (1046)
South Carolina (32)
Southern California (2594)
Tennessee (84)
Texas (1028)
United States (25241)
Utah (196)
Virginia (169)
Washington D.C. (60)
Washington State (606)
West Virginia (3)
Wisconsin (65)
600,056 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston
June 17, 2025
·
5 min read
Press Releases
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 5, 2025
·
5 min read
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
Can-Fite BioPharma Ltd. announces that its VP of Business Development, Dr. Sari Fishman, will hold 23 partnering meetings with Biotech & Pharma companies, who showed interest in partnering with Can-Fite.
May 27, 2024
·
5 min read
Press Releases
Can-Fite Reports 2024 Financial Results and Clinical Update
April 14, 2025
·
12 min read
Press Releases
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
April 15, 2025
·
5 min read
Drug Development
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
Can-Fite BioPharma Ltd. today announced an update on the status of its oncological lead drug candidate, Namodenoson in the treatment of advanced liver cancer.
June 5, 2024
·
6 min read
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
Can-Fite BioPharma Ltd. is pleased to invite investors to a webinar on June 6, 2024, at 4:15 p.m. ET.
May 23, 2024
·
5 min read
Career Advice
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs
In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.
June 25, 2025
·
4 min read
·
Michael Pietrack
Business
Can-Fite Reports 2023 Financial Results and Clinical Update
Can-Fite BioPharma Ltd. announced financial results and clinical updates for the twelve months ended December 31, 2023.
March 28, 2024
·
12 min read
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announces that company scientists came up with breakthrough findings showing that the anti-cancer and protective effects in the liver are conferred via the signalling protein adiponectin.
June 24, 2024
·
6 min read
1 of 60,006
Next
